Zimislecel is an allogeneic stem cell-derived islet cell therapy that could eliminate the need for insulin in those who have ...

Dad John Story said the introduction of "Lyla's Law" – routine testing for those showing symptoms – would be a "lasting ...

Tenofovir alafenamide (Vemlidy) for the initial treatment of chronic hepatitis B may confer modestly higher rates of complete and virologic response compared with entecavir (Baraclude), a ...

In 2025, that meant it was impossible for me to scroll through my feed without being visually assaulted by ingratiating ...

The epidemiology of hypertension in India has undergone a malignant shift, moving from a disease of the elderly to a ...

New evidence shows that remission in type 2 diabetes is attainable through weight loss, surgery, pharmacotherapy, and ...

BENGALURU: Early gestational diabetes mellitus (GDM) is emerging as a growing concern among pregnant women in India, with doctors warning that delayed detection ...

Rising metabolic disorders in India are fuelled by genetic predisposition, rapid lifestyle changes and hidden risk factors.

When scientists test algorithms that sort or classify data, they often turn to a trusted tool called Normalized Mutual Information (or NMI) to measure how well an algorithm's output matches reality.

India is not only the “diabetes capital” of the world but also the “diabetic retinopathy (DR) capital” too, said experts here. They attributed the la ...

An American Heart Association presidential advisory in 2023 introduced a new term: cardiovascular-kidney-metabolic syndrome.

India is not only the “diabetes capital” of the world but is also fast emerging as the “diabetic retinopathy capital,” ...